We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.19B
1-Year Est. Return 36.17%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+36.17%
3 Year Est. Return
+104%
5 Year Est. Return
+169.34%
10 Year Est. Return
AUM
$3.16B
AUM Growth
-$40.1M
Cap. Flow
-$284M
Cap. Flow %
-8.99%
Top 10 Hldgs %
49.77%
Holding
84
New
12
Increased
18
Reduced
29
Closed
15

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$90.5M
2
STLA icon
Stellantis
STLA
+$76.9M
3
AMAT icon
Applied Materials
AMAT
+$42.7M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$42.5M
5
AEE icon
Ameren
AEE
+$26.8M

Sector Composition

Rank Sector Weight
1 Technology 19.37%
2 Healthcare 15.12%
3 Materials 14.49%
4 Consumer Discretionary 12.16%
5 Communication Services 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECK icon
26
Teck Resources
TECK
$30.7B
$48.2M 1.52%
1,052,656
-852,155
-45% -$34.2M
GPN icon
27
Global Payments
GPN
$23.8B
$42.4M 1.34%
316,937
-223,833
-41% -$29.6M
IBKR icon
28
Interactive Brokers
IBKR
$40.3B
$33.3M 1.05%
1,193,288
-234,668
-16% -$5.84M
ALNY icon
29
Alnylam Pharmaceuticals
ALNY
$27.5B
$30.7M 0.97%
205,579
+16,438
+9% +$2.74M
AEE icon
30
Ameren
AEE
$30.1B
$27.9M 0.88%
+377,161
New +$26.8M
NE icon
31
Noble Corp
NE
$6.62B
$26.6M 0.84%
547,812
-11,737
-2% -$528K
JCI icon
32
Johnson Controls International
JCI
$87.2B
$23.6M 0.75%
360,968
+107,109
+42% +$6.24M
ROKU icon
33
Roku
ROKU
$21.5B
$23.4M 0.74%
359,328
-197,393
-35% -$15.4M
BEKE icon
34
KE Holdings
BEKE
$18.8B
$20.5M 0.65%
1,494,261
+1,481,935
+12,023% +$20.7M
ASAI
35
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$17.2M 0.54%
1,164,417
-25,424
-2% -$361K
KO icon
36
Coca-Cola
KO
$381B
$15.1M 0.48%
246,933
-413
-0.2% -$24.8K
VLRS
37
Controladora Vuela Compania de Aviacion
VLRS
$914M
$13.6M 0.43%
+1,832,109
New +$14.2M
COMP icon
38
Compass
COMP
$8.56B
$13M 0.41%
3,599,933
-13,070,553
-78% -$46.2M
GOOGL icon
39
Alphabet (Google) Class A
GOOGL
$4.08T
$8.75M 0.28%
+57,987
New +$8.3M
OTIS icon
40
Otis Worldwide
OTIS
$27.3B
$8.52M 0.27%
85,810
+443
+0.5% +$40.9K
TCOM icon
41
Trip.com Group
TCOM
$29.3B
$8.24M 0.26%
187,790
-199
-0.1% -$8.09K
BAH icon
42
Booz Allen Hamilton
BAH
$8.22B
$6.98M 0.22%
47,020
-61,647
-57% -$8.68M
NEM icon
43
Newmont
NEM
$101B
$5.66M 0.18%
157,950
SUZ icon
44
Suzano
SUZ
$10.4B
$3.83M 0.12%
299,848
-17,664
-6% -$199K
EXP icon
45
Eagle Materials
EXP
$6.3B
$3.68M 0.12%
13,537
NU icon
46
Nu Holdings
NU
$70B
$267K 0.01%
22,378
-7,271
-25% -$74.2K
ACIC icon
47
American Coastal Insurance
ACIC
$515M
$220K 0.01%
20,551
+602
+3% +$6.81K
GLOB icon
48
Globant
GLOB
$1.57B
$200K 0.01%
989
+17
+2% +$3.82K
ARES icon
49
PUT
Ares Management
ARES
$28B
$188K 0.01%
+1,578
New +$202K
DASH icon
50
DoorDash
DASH
$86.1B
$186K 0.01%
1,350

Similar funds

Antipodes Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Antipodes Partners held 84 positions worth $3.16B, down 1.3% from $3.2B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Antipodes Partners withdrew a net $284M in Q1 2024, closing 15 positions and reducing 29 holdings. Its most notable exit was Flowserve, an estimated $53.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Antipodes Partners opened a new position in Qualcomm worth $99.1M.

  • Antipodes Partners's largest Q1 2024 buy was Qualcomm: 585,590 shares worth $99.1M.
  • Antipodes Partners added most to Stellantis in Q1 2024, an estimated $76.9M increase.
  • Antipodes Partners's biggest Q1 2024 reduction was Compass, cutting an estimated $46.2M.
  • Antipodes Partners fully exited Flowserve in Q1 2024, selling an estimated $53.8M.
  • Antipodes Partners's ten largest holdings make up 50% of its $3.16B portfolio in Q1 2024.
  • Antipodes Partners opened 12 new positions and closed 15 in Q1 2024.
  • Antipodes Partners's portfolio value fell 1.3% quarter-over-quarter to $3.16B.

Based on Antipodes Partners's 13F filing for Q1 2024, filed 7 May 2024.